Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Misera Co. Ltd. has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is assigned to a distinct examiner, Caralynne E Helm, within a distinct art unit. Because the portfolio contains only 1 pending office action, all current prosecution activity is concentrated under this examiner. Practitioners should focus on the specific requirements of Caralynne E Helm for this case.
The absence of multiple pending actions means there is no opportunity for cross-case strategy within the Biotechnology & Pharmaceuticals technology area. The interaction with Caralynne E Helm will define the immediate success of the company's intellectual property efforts. With only 1 pending office action, the focus remains entirely on the assigned examiner's preferences.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HELM, CARALYNNE E | 1 | 28.9% | +49.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18575738 | SOLUTION FOR DESTROYING BIOFILMS AND METHOD OF PRODUCING THEREOF | HELM, CARALYNNE E | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18575738 | SOLUTION FOR DESTROYING BIOFILMS AND METHOD OF PRODUCING THEREOF | HELM, CARALYNNE E | — |
| Art Unit | Apps |
|---|---|
| 1615 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18575738 | SOLUTION FOR DESTROYING BIOFILMS AND METHOD OF PRODUCING THEREOF | HELM, CARALYNNE E | 1615 | §102§112 | Non-Final OA | — | Pending | Jan 24, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialMisera Co. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Caralynne E Helm has the most, with 1 of Misera Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
